Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks (Q73696601)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10774587%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10774587%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

5

J L Gerin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10774587%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

6

B C Tennant

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10774587%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

2

P Cote

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10774587%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

B E Korba

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10774587%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

W Hornbuckle

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10774587%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

R Schinazi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10774587%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10774587%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10774587%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10774587%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10774587%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

19-32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10774587%20AND%20SRC:MED&resulttype=core&format=json

Clinical experience with famciclovir against hepatitis B virus

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

New enzyme immunoassays for the serologic detection of woodchuck hepatitis virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

Inhibitory effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on woodchuck hepatitis virus replication in chronically infected woodchucks

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

Efficacy of the carbocyclic 2'-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

Pharmacodynamics of (-)-beta-2',3'-dideoxy-3'-thiacytidine in chronically virus-infected woodchucks compared to its pharmacodynamics in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

Experience with lamivudine against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

In vitro evaluation of combination therapies against hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

Hepadnavirus infection of peripheral blood lymphocytes in vivo: woodchuck and chimpanzee models of viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

Long-term therapy with the guanine nucleoside analog penciclovir controls chronic duck hepatitis B virus infection in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

Lamivudine therapy of WHV-infected woodchucks.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

The S-acyl-2-thioethyl pronucleotide approach applied to acyclovir: part I. Synthesis and in vitro anti-hepatitis B virus activity of bis(S-acyl-2-thioethyl)phosphotriester derivatives of acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

Core antigen and antibody in woodchucks after infection with woodchuck hepatitis virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

Heterogeneous response for a mammalian hepadnavirus infection to acyclovir: drug-arrested intermediates of minus-strand viral DNA synthesis are enveloped and secreted from infected cells as virion-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

Natural and experimental infection of woodchucks with woodchuck hepatitis virus, as measured by new, specific assays for woodchuck surface antigen and antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

Robustaflavone, a potential non-nucleoside anti-hepatitis B agent

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900072-8

7 January 2021

10.1016/S0166-3542(99)00072-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10774587%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference